Millennium Management »

Engene Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Engene Therapeutics shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $20k 69k 0.29

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Astrazeneca Ord Put Option (AZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology Put Option (MU)
Microsoft Corporation Call Option (MSFT)
Amazon Put Option (AMZN)
Advanced Micro Devices (AMD)
Apple (AAPL)
Meta Platforms Cl A Put Option (META)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Call Option (TSLA)

View all positions for Millennium Management

Top funds holding Engene Therapeutics

BVF
Blue Owl Capital Holdings
Caption Management
LMR Partners
Aristeia Capital
D. E. Shaw & Co
Millennium Management
Toronto-Dominion Bank
CSS
Intl Fcstone
Clear Street Group

View all funds holding Engene Therapeutics